Global Interventional Radiology Products Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Interventional Radiology Products Market Size

• The global interventional radiology products market size was valued at USD 25.79 billion in 2025 and is expected to reach USD 43.00 billion by 2033, at a CAGR of 6.60% during the forecast period
• The market growth is largely driven by the increasing adoption of minimally invasive procedures and continuous technological advancements in imaging-guided therapeutic devices, leading to improved precision and patient outcomes across multiple medical specialties
• Furthermore, the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and peripheral artery disease, along with growing demand for faster recovery, reduced hospital stays, and cost-effective treatments, is positioning interventional radiology products as a preferred solution in modern healthcare systems. These factors are significantly accelerating the global adoption of interventional radiology technologies, thereby boosting overall market growth

Interventional Radiology Products Market Analysis

• Interventional radiology products, including catheters, guidewires, embolization devices, stents, and imaging-guided systems, are increasingly essential components of modern healthcare as they enable minimally invasive procedures for diagnosing and treating a wide range of conditions, particularly in cardiovascular, oncology, and neurological interventions
• The rising demand for interventional radiology products is primarily driven by the growing prevalence of chronic diseases such as cancer and cardiovascular disorders, increasing preference for minimally invasive procedures, and continuous technological advancements in imaging and catheter-based therapeutic devices
• North America dominated the interventional radiology products market with the largest revenue share of 39.4% in 2025, characterized by advanced healthcare infrastructure, high adoption of minimally invasive treatment techniques, and a strong presence of major medical device manufacturers, with the U.S. witnessing significant growth in interventional procedures due to rising disease burden and expanding hospital-based imaging facilities
• Asia-Pacific is expected to be the fastest growing region in the interventional radiology products market during the forecast period due to improving healthcare infrastructure, increasing healthcare investments, and growing awareness regarding minimally invasive treatment options
• Catheters segment dominated the interventional radiology products market with a market share of 41.8% in 2025, driven by their extensive use in a wide range of image-guided procedures such as angioplasty, embolization, and targeted drug delivery

Report Scope and Interventional Radiology Products Market Segmentation         

Interventional Radiology Products Market Trends

“Rising Adoption of Advanced Image-Guided and Minimally Invasive Technologies”

• A significant and accelerating trend in the global interventional radiology products market is the increasing integration of advanced imaging technologies, robotics, and navigation systems that enhance the precision and effectiveness of minimally invasive therapeutic procedures across multiple clinical applications
• For instance, image-guided technologies such as cone-beam CT integrated with angiography systems allow physicians to visualize complex vascular structures in real time during procedures. Similarly, advanced robotic-assisted catheter navigation systems are being introduced to support highly precise vascular interventions and improve procedural accuracy
• Technological integration in interventional radiology devices enables improved procedural planning, precise device placement, and enhanced visualization of targeted tissues or blood vessels during treatment. For instance, some modern angiography platforms utilize advanced imaging algorithms to provide clearer anatomical mapping and support more accurate device navigation during complex interventions. Furthermore, improved imaging capabilities allow physicians to perform procedures with greater confidence and reduced risk to surrounding tissues
• The seamless integration of advanced interventional radiology devices with hospital imaging infrastructure and digital workflow platforms facilitates more efficient clinical decision-making and procedural coordination. Through unified imaging and device platforms, clinicians can manage diagnostic imaging, procedural planning, and therapeutic interventions within a single integrated environment
• This trend toward more precise, technology-driven, and minimally invasive treatment solutions is fundamentally transforming modern medical practice and expanding the role of interventional radiology across multiple specialties. Consequently, companies such as Philips and Siemens Healthineers are developing advanced image-guided therapy systems designed to enhance procedural efficiency and clinical outcomes
• The demand for interventional radiology products that offer advanced imaging integration and improved procedural capabilities is growing rapidly across hospitals and specialty clinics, as healthcare providers increasingly prioritize minimally invasive treatment options and improved patient recovery outcomes
• The growing use of artificial intelligence and advanced data analytics in interventional imaging platforms is further improving procedural planning, real-time visualization, and decision support, contributing to more efficient and accurate treatment outcomes

Interventional Radiology Products Market Dynamics

Driver

“Growing Need Due to Increasing Preference for Minimally Invasive Procedures and Rising Chronic Disease Burden”

• The increasing prevalence of chronic diseases such as cardiovascular disorders, cancer, and peripheral artery disease, coupled with the rising preference for minimally invasive treatment approaches, is a significant driver for the heightened demand for interventional radiology products
• For instance, in January 2025, Siemens Healthineers introduced an advanced angiography system designed to support complex interventional procedures with improved imaging precision and workflow efficiency. Such strategies by key companies are expected to drive the interventional radiology products industry growth in the forecast period
• As healthcare providers focus on reducing surgical risks and improving patient recovery times, interventional radiology techniques offer significant advantages such as smaller incisions, shorter hospital stays, and faster recovery compared with traditional surgical procedures
• Furthermore, the growing adoption of advanced imaging technologies and catheter-based therapeutic devices is making interventional radiology an essential component of modern treatment strategies across cardiology, oncology, and neurology specialties
• The ability to perform highly targeted procedures such as embolization, angioplasty, and tumor ablation using imaging guidance is a key factor propelling the adoption of interventional radiology products in hospitals and specialty care centers. The increasing investment in healthcare infrastructure and interventional radiology training programs further contributes to market growth
• The expanding geriatric population worldwide is further increasing the demand for minimally invasive treatments, as elderly patients often require less invasive procedures with shorter recovery periods and reduced surgical complications
• In addition, the rising number of specialized interventional radiology centers and hospital-based catheterization laboratories is supporting higher procedure volumes, thereby accelerating the demand for advanced interventional radiology devices

Restraint/Challenge

“High Procedure Costs and Complex Regulatory Approval Requirements”

• Concerns surrounding the high cost of advanced interventional radiology devices and the complexity of regulatory approval processes pose a significant challenge to broader market expansion. As these products involve sophisticated technology and strict safety requirements, manufacturers must navigate extensive regulatory evaluations before commercialization
• For instance, regulatory authorities such as the U.S. Food and Drug Administration and the European Medicines Agency require rigorous clinical validation and safety documentation before approving new interventional radiology devices for clinical use
• Addressing these regulatory challenges requires significant investment in research, clinical trials, and product validation processes to ensure compliance with safety and performance standards. Companies such as Boston Scientific and Medtronic emphasize strong clinical evidence and regulatory expertise to support the approval and adoption of their interventional radiology technologies. In addition, the high capital investment required for advanced imaging systems and specialized devices can be a barrier for smaller healthcare facilities
• While healthcare providers recognize the clinical benefits of minimally invasive procedures, the substantial upfront investment for imaging systems, procedural equipment, and specialist training may limit adoption in resource-constrained settings
• Limited availability of highly trained interventional radiologists and specialized clinical staff in certain regions can also restrict the adoption of advanced interventional radiology procedures
• Furthermore, concerns related to radiation exposure for both patients and healthcare professionals during certain image-guided procedures continue to require strict safety protocols and advanced shielding technologies, adding complexity to clinical implementation

Interventional Radiology Products Market Scope

The market is segmented on the basis of type, application, and end user.

• By Type

On the basis of type, the interventional radiology products market is segmented into stents, catheters, inferior vena cava (IVC) filters, embolization devices, thrombectomy systems, angioplasty balloons, biopsy needles, hemodynamic flow alteration devices, accessories, and other products. The catheters segment dominated the market with the largest market revenue share of 41.8% in 2025, primarily due to their extensive use in a wide range of minimally invasive procedures including angiography, angioplasty, and targeted drug delivery. Catheters serve as essential tools for guiding therapeutic devices to targeted anatomical locations with high precision under imaging guidance. Their versatility across cardiology, oncology, and peripheral vascular procedures significantly contributes to their widespread adoption in hospitals and specialized interventional centers. Continuous technological advancements, such as improved flexibility, enhanced navigation capabilities, and better material composition, further strengthen their role in complex procedures. In addition, the growing number of image-guided procedures globally continues to drive strong demand for catheter-based devices in interventional radiology.

The embolization devices segment is anticipated to witness the fastest growth rate from 2026 to 2033, fueled by the increasing use of embolization techniques in treating tumors, vascular malformations, and severe bleeding conditions. These devices are widely utilized in oncology procedures such as transarterial chemoembolization and radioembolization for targeted cancer therapy. The rising prevalence of cancer and the growing preference for minimally invasive treatment options are significantly contributing to the expansion of this segment. Technological advancements in embolic materials, including microspheres and liquid embolics, are enhancing treatment precision and clinical outcomes. Furthermore, embolization procedures offer advantages such as reduced hospital stays, minimal complications, and faster recovery times. These benefits are encouraging healthcare providers to increasingly adopt embolization technologies in interventional radiology practices.

• By Application

On the basis of application, the interventional radiology products market is segmented into cardiology, oncology, gastroenterology, neurology, orthopedics, urology and nephrology, and others. The cardiology segment dominated the market with the largest revenue share in 2025, driven by the high global prevalence of cardiovascular diseases and the widespread use of catheter-based procedures in cardiac interventions. Interventional radiology plays a crucial role in procedures such as angioplasty, stent placement, and vascular imaging that help restore blood flow in blocked arteries. The increasing number of patients suffering from coronary artery disease and peripheral vascular conditions continues to drive demand for these procedures. Technological advancements in cardiovascular imaging and device development further support the growth of this segment. Hospitals and cardiac centers increasingly rely on minimally invasive procedures to reduce surgical risks and recovery times. As a result, cardiology remains a key application area for interventional radiology products worldwide.

The oncology segment is expected to witness the fastest growth rate from 2026 to 2033, primarily due to the increasing use of image-guided therapies in cancer diagnosis and treatment. Interventional radiology techniques such as tumor ablation, chemoembolization, and radioembolization are becoming important alternatives to traditional cancer treatments. These minimally invasive approaches allow precise targeting of tumors while minimizing damage to surrounding healthy tissues. The growing global burden of cancer and rising awareness regarding advanced treatment options are further driving the adoption of interventional oncology procedures. Technological developments in imaging guidance and therapeutic devices are also improving procedural outcomes. As healthcare providers continue to focus on personalized and targeted therapies, the role of interventional radiology in oncology is expected to expand significantly.

• By End User

On the basis of end user, the interventional radiology products market is segmented into hospitals, clinics, and home care settings. The hospitals segment dominated the market with the largest revenue share in 2025, largely due to the availability of advanced imaging infrastructure and specialized medical professionals required to perform complex interventional procedures. Hospitals typically have well-equipped catheterization laboratories, angiography suites, and multidisciplinary teams capable of handling sophisticated image-guided treatments. The increasing number of interventional procedures performed in hospital settings also contributes to the dominance of this segment. In addition, hospitals often serve as referral centers for patients requiring specialized minimally invasive treatments. Continuous investments in advanced medical technologies and expanding healthcare infrastructure further strengthen hospital adoption of interventional radiology devices. As a result, hospitals remain the primary end users of these products globally.

The clinics segment is expected to witness the fastest growth rate from 2026 to 2033, driven by the increasing shift toward outpatient and ambulatory care services. Specialized clinics are increasingly performing minimally invasive procedures that do not require extended hospital stays, improving convenience for patients. Advances in compact imaging systems and portable interventional devices are enabling clinics to offer a broader range of radiology procedures. The growing focus on cost-effective healthcare delivery is also encouraging patients and providers to opt for clinic-based treatments whenever possible. In addition, the expansion of specialized interventional radiology centers is supporting the growth of this segment. As healthcare systems continue to emphasize efficient patient care and reduced hospitalization time, clinics are expected to play an increasingly important role in the interventional radiology ecosystem.

Interventional Radiology Products Market Regional Analysis

• North America dominated the interventional radiology products market with the largest revenue share of 39.4% in 2025, characterized by advanced healthcare infrastructure, high adoption of minimally invasive treatment techniques, and a strong presence of major medical device manufacturers
• Healthcare providers in the region highly value the clinical benefits, procedural precision, and improved patient outcomes offered by advanced interventional radiology technologies integrated with modern imaging systems and hospital infrastructures
• This widespread adoption is further supported by well-established healthcare infrastructure, strong presence of leading medical device manufacturers, and increasing investment in advanced imaging and minimally invasive treatment technologies, positioning interventional radiology products as essential tools in modern healthcare systems for both diagnostic and therapeutic procedures

U.S. Interventional Radiology Products Market Insight

The U.S. interventional radiology products market captured the largest revenue share of 82% in 2025 within North America, fueled by the strong adoption of minimally invasive procedures and the expanding use of advanced imaging technologies in clinical practice. Healthcare providers are increasingly prioritizing procedures that reduce surgical risks and improve patient recovery outcomes through image-guided interventions. The growing number of patients suffering from cardiovascular diseases, cancer, and vascular disorders further propels the demand for interventional radiology products. Moreover, the increasing integration of advanced imaging platforms, catheter-based devices, and robotic-assisted technologies in hospitals is significantly contributing to the market’s expansion.

Europe Interventional Radiology Products Market Insight

The Europe interventional radiology products market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by the growing demand for minimally invasive treatment options and advancements in medical imaging technologies. Increasing healthcare investments and the rising burden of chronic diseases are encouraging healthcare providers to adopt image-guided therapeutic procedures. European healthcare systems are also emphasizing early diagnosis and targeted treatment approaches to improve patient outcomes. The region is experiencing significant growth across hospitals and specialized treatment centers, with interventional radiology devices being increasingly utilized for cardiovascular, oncological, and neurological procedures.

U.K. Interventional Radiology Products Market Insight

The U.K. interventional radiology products market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by increasing adoption of minimally invasive procedures and strong government support for advanced healthcare technologies. In addition, the growing prevalence of chronic diseases and rising demand for efficient treatment options are encouraging healthcare providers to incorporate interventional radiology techniques. Hospitals across the country are investing in advanced imaging systems and specialized interventional radiology departments. The UK’s focus on improving healthcare efficiency and reducing patient recovery time is expected to continue to stimulate market growth.

Germany Interventional Radiology Products Market Insight

The Germany interventional radiology products market is expected to expand at a considerable CAGR during the forecast period, fueled by the country’s strong medical technology sector and growing demand for advanced diagnostic and therapeutic procedures. Germany’s well-developed healthcare infrastructure and emphasis on innovation support the adoption of cutting-edge interventional radiology technologies. Hospitals and research institutions are actively incorporating advanced imaging systems and minimally invasive treatment devices to improve clinical outcomes. The increasing focus on precision medicine and technologically advanced healthcare solutions is also contributing to the growth of the market in Germany.

Asia-Pacific Interventional Radiology Products Market Insight

The Asia-Pacific interventional radiology products market is poised to grow at the fastest CAGR during the forecast period of 2026 to 2033, driven by rapid healthcare infrastructure development, increasing healthcare expenditures, and rising awareness of minimally invasive treatment options in countries such as China, Japan, and India. The region's growing patient population and increasing prevalence of chronic diseases are accelerating the demand for interventional radiology procedures. Furthermore, government initiatives aimed at improving healthcare accessibility and expanding medical facilities are encouraging the adoption of advanced medical technologies across the region.

Japan Interventional Radiology Products Market Insight

The Japan interventional radiology products market is gaining momentum due to the country’s advanced healthcare infrastructure, aging population, and increasing demand for minimally invasive treatment procedures. The Japanese healthcare system places significant emphasis on precision medicine and advanced diagnostic technologies. The adoption of interventional radiology techniques is growing as hospitals integrate sophisticated imaging systems and specialized therapeutic devices into clinical practice. Moreover, Japan’s strong focus on technological innovation and patient-centered healthcare solutions is supporting the expansion of interventional radiology services across the country.

India Interventional Radiology Products Market Insight

The India interventional radiology products market accounted for the largest market revenue share in Asia Pacific in 2025, attributed to the country’s expanding healthcare infrastructure, rising prevalence of chronic diseases, and increasing adoption of advanced medical technologies. India is emerging as one of the fastest-growing markets for minimally invasive procedures due to the growing patient population and improving access to specialized healthcare services. The increasing number of hospitals equipped with advanced imaging facilities and interventional radiology departments is supporting market growth. In addition, government initiatives focused on strengthening healthcare systems and expanding medical technology adoption are key factors propelling the market in India.

Interventional Radiology Products Market Share

The Interventional Radiology Products industry is primarily led by well-established companies, including:

• Medtronic (Ireland)
• Boston Scientific Corporation (U.S.)
• Abbott (U.S.)
• BD (U.S.)
• Cardinal Health (U.S.)
• B. Braun SE Germany)
• Stryker Corporation (U.S.)
• Terumo Corporation (Japan)
• Cook (U.S.)
• Teleflex Incorporated (U.S.)
• AngioDynamics, Inc. (U.S.)
• BIOTRONIK SE & Co. KG (Germany)
• iVascular S.L.U. (Spain)
• Meril Life Sciences Pvt. Ltd. (India)
• Alvimedica (Turkey)
• Balton Sp. z o.o. (Poland)
• Medinol Ltd. (Israel)
• Rontis Medical SA (Switzerland)
• SCITECH Medical Products (Brazil)
• UreSil, LLC (U.S.)

What are the Recent Developments in Global Interventional Radiology Products Market?

• In July 2025, Medtronic announced the first patient enrollment in the PELE clinical study evaluating the Onyx Liquid Embolic System for treating peripheral arterial hemorrhage. The trial aims to assess the safety and effectiveness of the liquid embolic technology used in embolization procedures for vascular bleeding. The first procedure was performed at Albany Medical Center, representing a significant advancement in embolization therapies. This development highlights the continued clinical innovation in interventional radiology products used for minimally invasive vascular treatments
• In March 2025, Stryker announced the launch of the Artix™ Thrombectomy System, developed by Inari Medical, to treat arterial thrombus in the peripheral vascular system. The system combines aspiration and mechanical thrombectomy technologies to remove blood clots more effectively while giving physicians improved procedural control. The device is designed to address complex arterial clot cases and enhance outcomes in minimally invasive vascular procedures
• In February 2025, Guerbet received FDA Breakthrough Device designation for its Lipiojoint liquid embolic technology designed for embolization procedures. The designation is intended to accelerate the development and regulatory review of innovative devices that provide improved treatment for serious conditions. The embolic product is aimed at enhancing targeted vascular embolization procedures commonly used in oncology and vascular interventions
• In February 2025, Emboa Medical announced the launch of a novel thrombectomy catheter designed to improve clot retrieval during minimally invasive vascular procedures. The catheter is engineered to enhance navigation through complex blood vessels and support efficient removal of thrombus in endovascular treatments. Such device innovations are helping physicians perform more precise and safer procedures in interventional radiology. The launch demonstrates the growing emphasis on developing advanced catheter-based technologies for vascular interventions
• In January 2025, Inquis Medical announced the successful completion of patient enrollment in the AVENTUS clinical trial for its thrombectomy system designed to treat pulmonary embolism. The trial evaluates the safety and performance of the device in removing blood clots through minimally invasive catheter-based procedures. The technology is expected to improve treatment outcomes for patients suffering from severe venous thromboembolic conditions. This milestone reflects the growing clinical focus on advanced thrombectomy solutions within interventional radiology

SKU-26186